bioRxivImmunology
Modular Pooled Discovery of Synthetic Knockin Sequences to Program Durable Cell Therapies
F. Blaeschke, Y. Y. Chen, R. Apathy, Z. Li, C. T. Mowery, W. A. Nyberg, A. To, R. Yu, R. Bueno, M. C. Kim, R. Schmidt, D. B. Goodman, T. Feuchtinger, J. Eyquem, C. J. Ye, E. Shifrut, T. L. Roth, A. Marson
Abstract
Chronic stimulation can cause T cell dysfunction and limit efficacy of cellular immunotherapies. CRISPR screens have nominated gene targets for engineered T cells, but improved methods are required to compare large numbers of synthetic knockin sequences to reprogram cell functions. Here, we developed Modular Pooled Knockin Screening (ModPoKI), an adaptable platform for modular construction of DNA knockin libraries using barcoded multicistronic adaptors. We built two ModPoKI libraries of 100 transcription factors (TFs) and 129 natural and synthetic surface receptors. Over 20 ModPoKI screens across human TCR and CAR T cells in diverse conditions identified a transcription factor AP4 (TFAP4) construct to enhance long-term T cell fitness and anti-cancer function in vitro and in vivo. ModPoKIs modularity allowed us to generate a [~]10,000-member library of TF combinations. Non-viral knockin of a combined BATF-TFAP4 polycistronic construct further enhanced function in vivo. ModPoKI facilitates discovery of complex gene constructs to program cellular functions. HighlightsO_LIModular pooled knockins of hundreds of TF and surface receptor constructs combined with different antigen receptors C_LIO_LIChronic stimulation screens discover programs to improve T cell persistence C_LIO_LICombinatorial knockin screens with [~]10,000 transcription factor combinations C_LIO_LIBATF-TFAP4 dual knockin construct improves CAR T cell function in vitro and in vivo C_LI
- organism: human
- assay: CRISPR screen
- research focus: cell type annotation
- research focus: gene regulatory network inference
- research focus: drug response / drug discovery
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Rapid discovery of synthetic DNA sequences to rewrite endogenous T cell circuits
T. L. Roth, P. J. Li, … A. Marson·bioRxiv·Apr 12, 2019
- DNA-Dependent Protein Kinase Inhibitors PI-103 and Samotolisib Augment CRISPR/Cas9 Knockin Efficiency in Human T Cells
Emina Džafo, Morteza Hafezi, … Bernhard Gentner·CytotherapyPeer-reviewed·Feb 10, 2025
- In vivo genome-wide CRISPR screens in human T cells to enhance T cell therapy for solid tumors
Qi Liu, Peixin Amy Chen, … Julia C. Carnevale·bioRxiv·Sep 23, 2025
- Genome-wide CRISPRa screens nominate modulators of CAR T cell survival within distinct tumor cytokine milieus
B. C. Curtis, C. H. Spurrell, … M. C. Jensen·bioRxiv·Mar 16, 2024
- In vivo CRISPR screens identify key modifiers of CAR T cell function in myeloma
Nelson H. Knudsen, Giulia Escobar, … Marcela Valderrama Maus·NaturePeer-reviewed·Sep 24, 2025
- Enhanced Effector Activity of Mediator Kinase Module Deficient CAR-T Cells
K. A. Freitas, J. A. Belk, … C. L. Mackall·bioRxiv·Sep 2, 2022